Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant TS-1 and Cisplatin vs Surgery Alone for Type 4 and Large Type 3 Gastric Cancer
NCT00252161Phase 3Completed
- Start
- Nov 2005
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tegafur and cisplatin in gastric cancer (GC) (2 arms). Primary endpoint: Overall Survival. Started Nov 2005; status: completed.
02
Drugs
tegafurcisplatin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00252161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00252161.